Cumberland Pharmaceuticals Inc SEC filings CPIX
Cumberland Pharmaceuticals Inc has 1,000 filings in SEC EDGAR's recent list, going back to Mar 18, 2009. Its latest annual report, Form ARS, was filed on Mar 12, 2026 for the period ended Mar 12, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFM14A | Filing | May 26, 2026 | — |
| PREM14A | Filing | May 15, 2026 | May 15, 2026 |
| DEFA14A | Additional proxy material | Apr 23, 2026 | — |
| DEFA14A | Additional proxy material | Mar 9, 2026 | — |
| DEF 14A | Proxy statement | Mar 9, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Mar 10, 2025 | — |
| DEF 14A | Proxy statement | Mar 10, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Mar 13, 2024 | — |
| DEF 14A | Proxy statement | Mar 13, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Mar 15, 2023 | — |
| DEF 14A | Proxy statement | Mar 15, 2023 | Mar 15, 2023 |
| DEF 14A | Proxy statement | Mar 16, 2022 | Apr 28, 2022 |
| DEF 14A | Proxy statement | Mar 15, 2021 | Apr 27, 2021 |
| DEF 14A | Proxy statement | Mar 20, 2020 | May 5, 2020 |
| DEF 14A | Proxy statement | Mar 14, 2019 | Apr 23, 2019 |
| DEF 14A | Proxy statement | Mar 15, 2018 | Apr 24, 2018 |
| DEFA14A | Additional proxy material | Mar 15, 2018 | — |
| DEF 14A | Proxy statement | Mar 16, 2017 | Apr 25, 2017 |
| DEFA14A | Additional proxy material | Mar 16, 2017 | — |
| DEFA14A | Additional proxy material | Mar 29, 2016 | — |
| DEF 14A | Proxy statement | Mar 16, 2016 | Apr 26, 2016 |
| DEFA14A | Additional proxy material | Mar 13, 2015 | — |
| DEF 14A | Proxy statement | Mar 13, 2014 | Mar 12, 2014 |
| DEF 14A | Proxy statement | Mar 14, 2013 | Apr 16, 2013 |
| DEF 14A | Proxy statement | Mar 12, 2012 | Apr 17, 2012 |
| DEF 14A | Proxy statement | Mar 14, 2011 | Apr 19, 2011 |
| DEF 14A | Proxy statement | Mar 22, 2010 | Apr 20, 2010 |
Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CPIX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- TN
- Headquarters
- Nashville,, TN
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1087294
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.